Coverage at a glance
| Indication | Coverage |
|---|---|
| Obesity / weight loss only, standard Part D | Not covered |
| Wegovy and Zepbound on Humana's 2026 Medicare drug lists | Not covered |
| Obesity / weight loss through the Medicare GLP-1 Bridge | Covered with prior authorization |
If your plan denies coverage, two cash programs to check.
- Strut Health$149 a month, with auto-refillcompounded semaglutideCheck price →
- Shed$199 a monthcompounded semaglutideCheck price →A health form first, then you choose your plan
Cheapest GLP-1 without insurance compares the three cash routes. Cheapest GLP-1 ranks every cash price on the chart.
Prior authorization: the plan reviews the prescription before it pays.
The 2026 HumanaChoice, Premier Rx and Value Rx drug guides do not list either drug. Humana's Medicare page says standard Part D plans do not cover GLP-1 drugs used only for weight loss, and that Part D can cover Ozempic or Wegovy when the prescription is for diabetes or cardiovascular disease. The one covered weight-loss route is the Medicare GLP-1 Bridge, a CMS program that runs to December 31, 2027. This answer covers Medicare Advantage plans with drug coverage, and Humana standalone Medicare Part D plans.
Source: Humana, Does Medicare cover GLP-1 weight loss drugs? (updated 06/08/2026). Checked September 7, 2026.
What this page covers. Humana told the SEC on February 23, 2023 that it was exiting the employer group commercial medical products business, so this page covers its Medicare plans. Humana Inc. Form 8-K, February 23, 2023
What it costs if they say yes. Government plans are barred from the manufacturer savings cards, so the copay is whatever your plan sets. What Wegovy costs on Medicare. What Zepbound costs on Medicare.
Coverage by indication
Humana's own Medicare page says standard Medicare Part D drug plans do not cover GLP-1 medications used only for weight loss. The same page says Part D may cover drugs like Ozempic and Wegovy when they are prescribed for diabetes management or cardiovascular disease.
Source: Humana, Does Medicare cover GLP-1 weight loss drugs? (updated 06/08/2026). Humana's own member page, read as HTML.
Humana's HumanaChoice, Premier Rx and Value Rx 2026 drug guides do not list Wegovy or Zepbound. All three carry Ozempic and Mounjaro at tier 3 with prior authorization and a quantity limit, and the HumanaChoice list carries Rybelsus on the same terms.
What the prior authorization needs:
- Not on the HumanaChoice (PPO) 2026 drug guide, formulary 26408
- Not on the Humana Premier Rx Plan (PDP) 2026 drug guide, formulary 26402
- Not on the Humana Value Rx Plan (PDP) 2026 drug guide, formulary 26400
Source: Humana policy Y0040_PDG26_FINAL_15C_C. The plan's own covered-drug list.
The Bridge runs outside the Part D payment flow. It covers Wegovy and Foundayo, the oral GLP-1, in any form, plus the Zepbound KwikPen, and only where the prescription is for weight loss. A prescription for type 2 diabetes or cardiovascular risk goes through standard Part D instead.
What the prior authorization needs:
- You have to be enrolled in a standalone Part D drug plan or a Medicare Advantage plan with drug coverage
- Your doctor has to diagnose obesity
- Your doctor has to show a medical need for drug treatment as part of a weight management plan
- Your doctor sends the prior authorization request and the prescription to a CMS central processor, which checks that you qualify and pays the claim
Source: Humana, Does Medicare cover GLP-1 weight loss drugs? (updated 06/08/2026). Humana's own member page, read as HTML.
Obstructive sleep apnea: the Humana weight-loss drug policy names no separate route for it. Zepbound's FDA label carries the indication, so ask the plan which policy applies to it.
Medicare GLP-1 Bridge: The Medicare GLP-1 Bridge has run since July 1, 2026, and it ends on December 31, 2027. It is a CMS test program for Part D, not a Humana benefit. A Part D member who qualifies pays $50 for Wegovy and Foundayo in any form, plus the Zepbound KwikPen. Not the single-dose vials or pens, so the prescription has to say KwikPen. No plan has to join, but CMS sets the clinical rules and your doctor files for a sign-off. If you have type 2 diabetes, moderate to severe obstructive sleep apnea, or MASH without cirrhosis, Part D can cover these drugs for that diagnosis, and that puts you outside the Bridge.
Ozempic, Mounjaro and Rybelsus on Humana plans
Ozempic, Mounjaro and Rybelsus are approved for type 2 diabetes, not weight loss.
Does Humana cover Ozempic?
Yes, with prior approval. Humana pays for Ozempic once your prescriber gets the plan to sign off.
Humana's 2026 Medicare Part D drug lists cover Ozempic for type 2 diabetes, its only FDA-approved use. The plan has to sign off, and a quantity limit of 3 pens per 28 days applies. Ozempic sits at tier 3 on the Premier Rx, Value Rx and HumanaChoice 2026 lists, and none of them makes you try another drug first. Part D does not cover drugs used only for weight loss, and Ozempic has no weight-loss approval. Wegovy is the same semaglutide at a higher dose, approved for weight loss.
What Humana requires for Ozempic
| Step therapy | Not required |
What the prior authorization needs:
- Prior authorization (PA) required
- Quantity limit (QL): 3 pens per 28 days
- Tier 3 on the 2026 Premier Rx Plan (PDP), Value Rx Plan (PDP) and HumanaChoice (PPO) guides (updated 09/02/2026)
- The HumanaChoice list also carries the Ozempic tablet at tier 3, with a quantity limit of 30 tablets per 30 days
Source: Humana policy Y0040_PDG26_FINAL_5C_C. The plan's own covered-drug list.
Recent change: Humana updated the three 2026 Part D drug lists cited here on September 2, 2026.
Does Humana cover Mounjaro?
Yes on some plans. Humana publishes a different drug list for each plan it sells, so two people with the same insurer can get different answers.
Humana lists Mounjaro as a covered brand drug for type 2 diabetes on its 2026 Medicare Part D drug lists. Mounjaro is tirzepatide. On the Humana Value Rx Plan and the Humana Premier Rx Plan it sits at tier 3, the plan has to sign off, and a quantity limit of 2 pens per 28 days applies. The FDA approved Mounjaro for type 2 diabetes only. Part D does not cover drugs used only for weight loss, so it will not pay for Mounjaro prescribed to lose weight. Zepbound is the weight-loss form of the same tirzepatide, and Part D does not cover that either.
What Humana requires for Mounjaro
| Step therapy | Not required |
What the prior authorization needs:
- Tier 3 on both 2026 lists cited here, the Humana Value Rx Plan (PDP), formulary 26400 and the Humana Premier Rx Plan (PDP), formulary 26402
- The plan has to sign off first, and a quantity limit of 2 pens per 28 days applies
- Not covered when it is prescribed for weight loss, because Part D does not cover drugs used only for weight loss
Source: Humana Formulary 26400 (Y0040_PDG26_FINAL_3C_C). The plan's own covered-drug list.
Does Humana cover Rybelsus?
Yes on some plans. Humana publishes a different drug list for each plan it sells, so two people with the same insurer can get different answers.
Some of Humana's 2026 Medicare Part D drug lists cover Rybelsus for type 2 diabetes. The tier and the rules differ by plan. On the HumanaChoice (PPO) 2026 list Rybelsus sits at tier 3, the plan has to sign off, and a quantity limit of 30 tablets per 30 days applies. The Premier Rx and Value Rx standalone Part D lists do not carry it. Rybelsus has no weight-loss approval, so Part D will not cover it for weight loss. Wegovy is the semaglutide approved for weight loss.
What Humana requires for Rybelsus
| Step therapy | Not required |
What the prior authorization needs:
- Tier 3 on the HumanaChoice (PPO) 2026 drug guide, formulary 26408
- The plan has to sign off first, and a quantity limit of 30 tablets per 30 days applies
- The Humana Premier Rx Plan (PDP) and Humana Value Rx Plan (PDP) 2026 drug lists do not carry Rybelsus
- Check your own plan's drug list before you fill the prescription
Source: Humana policy Y0040_PDG26_FINAL_15C_C. The plan's own covered-drug list.
What to do next
If you qualify under one of the covered indications above, prior authorization is the path. Match the documentation in the requirements list then have your prescriber submit it. Plans that approve reassess at renewal, so know your long-term maintenance dose before you start.
- Browse the prior-authorization letter library for a template that matches your plan and indication.
- Read why plans say no and the four ways to appeal in the GLP-1 insurance guide.
- Your plan may treat another GLP-1 differently. The Humana coverage check lists all 4, with the source for each.
- If the plan denies it, the appeal letter library has a template for each reason a plan gives. That covers the peer-to-peer call with a plan doctor, the Level 1 and Level 2 appeals inside the plan, and the outside review that follows them.
- If your plan does not cover the indication you need, compare cash prices in the cost guide or check whether a clinical trial near you fits. Neither one goes through your insurer. Clinical trials cost nothing and many pay you for your time.
What it costs without insurance
The programs below bill you directly. Prices checked every Monday.
Frequently asked questions
Does Humana cover Wegovy or Zepbound?
Not on the Medicare drug lists it publishes. Wegovy and Zepbound are not on the 2026 HumanaChoice (PPO) guide or the Premier Rx and Value Rx standalone Part D guides. Humana's Medicare page says standard Part D plans do not cover GLP-1 drugs used only for weight loss.
Can a Humana Medicare member get Wegovy or Zepbound at all?
Through the Medicare GLP-1 Bridge, if you qualify. It is a CMS program open to people enrolled in a standalone Part D drug plan or a Medicare Advantage plan with drug coverage. Your doctor has to diagnose obesity, show a medical need for drug treatment, and send a prior authorization request to a CMS central processor. It covers Foundayo, Wegovy and the Zepbound KwikPen, and it ends on December 31, 2027.
Does Humana cover Wegovy or Zepbound on a job-based plan?
Humana told the SEC on February 23, 2023 that it was exiting the employer group commercial medical products business. The drug lists it publishes for 2026 are Medicare Part D lists.
Does Humana cover Zepbound for sleep apnea?
The Humana weight-loss drug policy names no separate obstructive sleep apnea route. Zepbound's FDA label carries the sleep apnea indication, so ask the plan which policy applies to it. Source: Humana, Does Medicare cover GLP-1 weight loss drugs? (updated 06/08/2026), read September 2026.
Coverage for other payers
See the full payer coverage index for every plan we have sourced.
How we built this page
Every page here comes from the payer's own policy, a federal law, or KFF's plan research. Each row links its source and gives the date we read it. Some plan files load at the address the payer gives but will not open. We check those against a second source and mark the row lower confidence. Job-based plans also choose whether to add the weight-drug benefit at all, so those rows say varies by plan rather than a flat yes.
This is reference information, not medical or legal advice, and not a guarantee of coverage. GLP-1 coverage policies change often. Always confirm the current policy with your insurer using the number on your card before you rely on this page. If your experience differs from what is shown here, email hello@glpchart.com with the details and we will re-verify.
